IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q2 P&L / Income Statement

IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

1,216,585,000 US dollars

Cost of revenue from reportable segments

437,498,000 US dollars

Gross profit

779,087,000 US dollars

Total operating expenses

353,521,000 US dollars

Income from operations

425,566,000 US dollars

Other income (expense), net (calculated)

negative 8,342,000 US dollars

Income before provision for income taxes

417,224,000 US dollars

Provision for income taxes

78,812,000 US dollars

Net income

338,412,000 US dollars

CAG segment revenue

1,118,236,000 US dollars

Water segment revenue

58,564,000 US dollars

LPD segment revenue

35,181,000 US dollars

Research and development

65,429,000 US dollars

Sales and marketing

171,277,000 US dollars

General and administrative

116,815,000 US dollars

Revenue before reconciliation (calculated)

1,211,981,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Other revenue

4,604,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.